Articles with public access mandates - Mohammad Obaidul Hoque, DDS. Ph.D.Learn more
Not available anywhere: 1
Differences in the Molecular Characteristics of Bladder Cancer between Smokers and Nonsmokers
MO Hoque
European Urology Focus 4 (1), 98-99, 2018
Mandates: US National Institutes of Health
Available somewhere: 66
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors
E Izumchenko, K Paz, D Ciznadija, I Sloma, A Katz, D Vasquez-Dunddel, ...
Annals of Oncology 28 (10), 2595-2605, 2017
Mandates: US National Institutes of Health, National Institute for Health Research, UK
Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission
M Loyo, R Guerrero‐Preston, M Brait, MO Hoque, A Chuang, MS Kim, ...
International journal of cancer 126 (12), 2991-2996, 2010
Mandates: US National Institutes of Health
Genome-wide promoter analysis uncovers portions of the cancer methylome
MO Hoque, MS Kim, KL Ostrow, J Liu, GBA Wisman, HL Park, ML Poeta, ...
Cancer research 68 (8), 2661-2670, 2008
Mandates: US National Institutes of Health
Targeting cancer stem cells: a strategy for effective eradication of cancer
M Shibata, MO Hoque
Cancers 11 (5), 732, 2019
Mandates: US National Institutes of Health
Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR
KL Ostrow, MO Hoque, M Loyo, M Brait, A Greenberg, JM Siegfried, ...
Clinical Cancer Research 16 (13), 3463-3472, 2010
Mandates: US National Institutes of Health
An epigenetic marker panel for detection of lung cancer using cell-free serum DNA
S Begum, M Brait, S Dasgupta, KL Ostrow, M Zahurak, AL Carvalho, ...
Clinical Cancer Research 17 (13), 4494-4503, 2011
Mandates: US National Institutes of Health
A panel of novel detection and prognostic methylated DNA markers in primary non–small cell lung cancer and serum DNA
A Ooki, Z Maleki, JCJ Tsay, C Goparaju, M Brait, N Turaga, HS Nam, ...
Clinical Cancer Research 23 (22), 7141-7152, 2017
Mandates: US National Institutes of Health
Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
E Izumchenko, X Chang, M Brait, E Fertig, LT Kagohara, A Bedi, ...
Nature communications 6 (1), 8258, 2015
Mandates: US National Institutes of Health
The TGFβ–miR200–MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors
E Izumchenko, X Chang, C Michailidi, L Kagohara, R Ravi, K Paz, M Brait, ...
Cancer research 74 (14), 3995-4005, 2014
Mandates: US National Institutes of Health
A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy
M Shibata, K Ham, MO Hoque
International journal of cancer 143 (9), 2133-2144, 2018
Mandates: US National Institutes of Health
KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses
S Demokan, X Chang, A Chuang, WK Mydlarz, J Kaur, P Huang, Z Khan, ...
International journal of cancer 127 (10), 2351-2359, 2010
Mandates: US National Institutes of Health
Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance
AL Carvalho, R Henrique, C Jeronimo, CS Nayak, AN Reddy, MO Hoque, ...
Clinical cancer research 17 (14), 4782-4789, 2011
Mandates: US National Institutes of Health
Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression
MO Hoque, M Prencipe, ML Poeta, R Barbano, VM Valori, M Copetti, ...
Cancer epidemiology, biomarkers & prevention 18 (10), 2694-2700, 2009
Mandates: US National Institutes of Health
Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer
M Brait, S Begum, AL Carvalho, S Dasgupta, AL Vettore, B Czerniak, ...
Cancer Epidemiology Biomarkers & Prevention 17 (10), 2786-2794, 2008
Mandates: US National Institutes of Health
YAP1 and COX2 coordinately regulate urothelial cancer stem-like cells
A Ooki, M Del Carmen Rodriguez Pena, L Marchionni, W Dinalankara, ...
Cancer research 78 (1), 168-181, 2018
Mandates: US National Institutes of Health
A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma
M Loyo, M Brait, MS Kim, KL Ostrow, CC Jie, AY Chuang, JA Califano, ...
International journal of cancer 128 (6), 1393-1403, 2011
Mandates: US National Institutes of Health
Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer
M Brait, M Loyo, E Rosenbaum, KL Ostrow, A Markova, S Papagerakis, ...
Epigenetics 7 (7), 710-719, 2012
Mandates: US National Institutes of Health
Pharmacologic unmasking of epigenetically silenced genes in breast cancer
KL Ostrow, HL Park, MO Hoque, MS Kim, J Liu, P Argani, W Westra, ...
Clinical Cancer Research 15 (4), 1184-1191, 2009
Mandates: US National Institutes of Health
Association between lifestyle factors and CpG island methylation in a cancer-free population
M Brait, JG Ford, S Papaiahgari, MA Garza, JI Lee, M Loyo, L Maldonado, ...
Cancer epidemiology, biomarkers & prevention 18 (11), 2984-2991, 2009
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program